Elucidating the precise pharmacological system of action (MOA) of naturally developing compounds is often tough. While Tarselli et al. (60) made the very first de novo synthetic pathway to conolidine and showcased this naturally happening compound effectively suppresses responses to the two chemically induced and inflammation-derived pain, the phar… Read More